Medical device companies scaling under FDA and EU MDR pressure often pass audits, yet still face submission delays, engineering diversions, and leadership uncertainty at critical milestones.
This white paper explores why audit success no longer predicts operational readiness, where traditional QMS approaches break down at scale, and how modern MedTech teams are building continuous readiness into their quality systems to protect product velocity and business outcomes.
